17034
Combination with ICS ( fluticasone / salmeterol , budesonide / formoterol , beclomethasone / formoterol ) appears to provide an additional benefit over the monocomponent therapy , although the extent of this benefit is variable and often not clinically significant in all the endpoints assessed .
 Chemical: fluticasone; Chemical: salmeterol; Chemical: budesonide; Chemical: formoterol; Chemical: beclomethasone; Chemical: formoterol
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: fluticasone; Chemical: salmeterol; Chemical: budesonide; Chemical: formoterol; Chemical: beclomethasone; Chemical: formoterol